It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Social-communication (SC) and restricted repetitive behaviors (RRB) are autism diagnostic symptom domains. SC and RRB severity can markedly differ within and between individuals and may be underpinned by different neural circuitry and genetic mechanisms. Modeling SC-RRB balance could help identify how neural circuitry and genetic mechanisms map onto such phenotypic heterogeneity. Here, we developed a phenotypic stratification model that makes highly accurate (97–99%) out-of-sample SC = RRB, SC > RRB, and RRB > SC subtype predictions. Applying this model to resting state fMRI data from the EU-AIMS LEAP dataset (n = 509), we find that while the phenotypic subtypes share many commonalities in terms of intrinsic functional connectivity, they also show replicable differences within some networks compared to a typically-developing group (TD). Specifically, the somatomotor network is hypoconnected with perisylvian circuitry in SC > RRB and visual association circuitry in SC = RRB. The SC = RRB subtype show hyperconnectivity between medial motor and anterior salience circuitry. Genes that are highly expressed within these networks show a differential enrichment pattern with known autism-associated genes, indicating that such circuits are affected by differing autism-associated genomic mechanisms. These results suggest that SC-RRB imbalance subtypes share many commonalities, but also express subtle differences in functional neural circuitry and the genomic underpinnings behind such circuitry.
Natasha Bertelsen et al. develop a computational model to categorize patients with autism spectrum disorder (ASD) into distinct subgroups, based on social-communicative or restricted repetitive behaviors. By integrating publicly available neuroimaging and genetic data, they report neural and molecular signatures in two of these subgroups, altogether highlighting subtle differences in neural circuitry and genomic networks that could underlie phenotypic differences among ASD patients.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Istituto Italiano di Tecnologia, Laboratory for Autism and Neurodevelopmental Disorders, Center for Neuroscience and Cognitive Systems @UniTn, Rovereto, Italy (GRID:grid.25786.3e) (ISNI:0000 0004 1764 2907); University of Trento, Center for Mind/Brain Sciences, Rovereto, Italy (GRID:grid.11696.39) (ISNI:0000 0004 1937 0351)
2 Istituto Italiano di Tecnologia, Laboratory for Autism and Neurodevelopmental Disorders, Center for Neuroscience and Cognitive Systems @UniTn, Rovereto, Italy (GRID:grid.25786.3e) (ISNI:0000 0004 1764 2907)
3 University of Cambridge, Department of Psychiatry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
4 Children’s Hospital of Philadelphia, Department of Child and Adolescent Psychiatry and Behavioral Science, Philadelphia, USA (GRID:grid.239552.a) (ISNI:0000 0001 0680 8770); University of Pennsylvania, Department of Psychiatry, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
5 Istituto Italiano di Tecnologia, Laboratory for Autism and Neurodevelopmental Disorders, Center for Neuroscience and Cognitive Systems @UniTn, Rovereto, Italy (GRID:grid.25786.3e) (ISNI:0000 0004 1764 2907); University of Cyprus, Department of Psychology, Nicosia, Cyprus (GRID:grid.6603.3) (ISNI:0000000121167908)
6 University of Edinburgh, Department of Psychology, School of Philosophy, Psychology, and Language Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); University of Cambridge, Autism Research Centre, Department of Psychiatry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
7 University of Cambridge, Brain Mapping Unit, Department of Psychiatry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
8 King’s College London, Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); King’s College London, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
9 Université de Paris, Human Genetics and Cognitive Functions, Institut Pasteur, UMR3571 CNRS, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602)
10 University of Heidelberg, Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Mannheim, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)
11 Radboud University Medical Centre, Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382)
12 Karolinska Institutet & Stockholm Health Care Services, Region Stockholm, Department of Women’s and Children’s Health; Center of Neurodevelopmental Disorders (KIND), Centre for Psychiatry Research, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Child and Adolescent Psychiatry, Stockholm Health Care Services, Stockholm, Sweden (GRID:grid.467087.a) (ISNI:0000 0004 0442 1056); Curtin University, Curtin Autism Research Group, School of Occupational Therapy, Social Work and Speech Pathology, Perth, Australia (GRID:grid.1032.0) (ISNI:0000 0004 0375 4078)
13 King’s College London, Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
14 University Medical Center Utrecht, Department of Psychiatry, Brain Center Rudolf Magnus, Utrecht, The Netherlands (GRID:grid.7692.a) (ISNI:0000000090126352)
15 University Hospital Frankfurt am Main, Goethe University, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Frankfurt, Germany (GRID:grid.7692.a)
16 University of Cambridge, Autism Research Centre, Department of Psychiatry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
17 University of Cambridge, Department of Psychology, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
18 Centre for Brain and Cognitive Development, Birkbeck, University of London, Henry Wellcome Building, London, UK (GRID:grid.4464.2) (ISNI:0000 0001 2161 2573)
19 University of Heidelberg, Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Mannheim, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)
20 Radboud University Medical Centre, Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382); Monash University, Turner Institute for Brain and Mental Health, School of Psychological Sciences, Victoria, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
21 University of Messina, Child and Adolescent Neuropsychiatry Unit, Gaetano Martino University Hospital, Messina, Italy (GRID:grid.10438.3e) (ISNI:0000 0001 2178 8421); University Campus Bio-Medico, Rome, Italy (GRID:grid.9657.d) (ISNI:0000 0004 1757 5329)
22 King’s College London, Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764); University of Vienna, Department of Applied Psychology: Health, Development, Enhancement, and Intervention, Vienna, Austria (GRID:grid.10420.37) (ISNI:0000 0001 2286 1424)
23 Psychology and Neuroscience, King’s College London, Department of Neuroimaging, Institute of Psychiatry, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
24 Roche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland (GRID:grid.13097.3c)
25 King’s College London, Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
26 University Campus Bio-Medico, Rome, Italy (GRID:grid.9657.d) (ISNI:0000 0004 1757 5329)
27 Roche Pharma Research and Early Development, Neuroscience, Ophthalmology and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland (GRID:grid.5335.0)
28 King’s College London, Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
29 Neurospin Centre CEA, Gif sur Yvette, France (GRID:grid.13097.3c)
30 Regulatory Affairs, Product Development, F. Hoffmann-La Roche Pharmaceuticals, Basel, Switzerland (GRID:grid.417570.0) (ISNI:0000 0004 0374 1269)
31 Janssen Research & Development, Titusville, USA (GRID:grid.497530.c) (ISNI:0000 0004 0389 4927)
32 King’s College London, Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
33 King’s College London, Department of Child and Adolescent Psychiatry, Institute of Psychology, Psychiatry and Neuroscience, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)
34 University of Cambridge, Autism Research Centre, Department of Psychiatry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); Centre for Addiction and Mental Health, The Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, Azrieli Adult Neurodevelopmental Centre, and Campbell Family Mental Health Research Institute, Toronto, Canada (GRID:grid.155956.b) (ISNI:0000 0000 8793 5925); The Hospital for Sick Children, Department of Psychiatry and Autism Research Unit, Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Psychiatry, Faculty of Medicine, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938); National Taiwan University Hospital and College of Medicine, Department of Psychiatry, Taipei, Taiwan (GRID:grid.412094.a) (ISNI:0000 0004 0572 7815)
35 Istituto Italiano di Tecnologia, Laboratory for Autism and Neurodevelopmental Disorders, Center for Neuroscience and Cognitive Systems @UniTn, Rovereto, Italy (GRID:grid.25786.3e) (ISNI:0000 0004 1764 2907); University of Cambridge, Autism Research Centre, Department of Psychiatry, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)